1. Home
  2. BVS vs CCAP Comparison

BVS vs CCAP Comparison

Compare BVS & CCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioventus Inc.

BVS

Bioventus Inc.

N/A

Current Price

$8.60

Market Cap

482.9M

Sector

Health Care

ML Signal

N/A

Logo Crescent Capital BDC Inc.

CCAP

Crescent Capital BDC Inc.

N/A

Current Price

$12.68

Market Cap

492.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BVS
CCAP
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
482.9M
492.4M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
BVS
CCAP
Price
$8.60
$12.68
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$14.25
$16.33
AVG Volume (30 Days)
305.4K
173.3K
Earning Date
06-15-2026
01-01-0001
Dividend Yield
N/A
13.11%
EPS Growth
163.46
N/A
EPS
0.33
N/A
Revenue
$568,087,000.00
N/A
Revenue This Year
$7.42
N/A
Revenue Next Year
$6.46
N/A
P/E Ratio
$26.97
$14.18
Revenue Growth
N/A
N/A
52 Week Low
$5.81
$12.56
52 Week High
$10.13
$17.97

Technical Indicators

Market Signals
Indicator
BVS
CCAP
Relative Strength Index (RSI) 52.95 34.97
Support Level $6.42 $12.56
Resistance Level $9.01 $14.70
Average True Range (ATR) 0.39 0.44
MACD -0.03 -0.02
Stochastic Oscillator 35.19 12.75

Price Performance

Historical Comparison
BVS
CCAP

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About CCAP Crescent Capital BDC Inc.

Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.

Share on Social Networks: